Latest News & Features
Big Pharma
The Alternative Dispute Resolution Forum has ruled in a case between Gilead Sciences and a company called PublicDomainRegistry.com, in another battle centred on Gilead’s hepatitis C drug Sovaldi. 1 August 2016
Americas
Novartis has filed complaint against Teva claiming the Israel-based company allegedly infringed one of its patents covering the drug Jadenu. 1 August 2016
Americas
Pharmaceutical company Vectura has sued GSK for allegedly infringing its patent after claiming that it refused to expand on a licensing agreement. 29 July 2016
Big Pharma
Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business. 28 July 2016
Americas
Teva announced yesterday that the Federal Trade Commission has accepted its proposed $40.5 billion buyout of Allergan’s generics business after the Isreal-based company agreed to sell nearly 80 products to address competition concerns. 28 July 2016
Americas
Bayer and Janssen Pharmaceuticals have sued Breckenridge Pharmaceutical for allegedly infringing two patents related to the deep vein thrombosis treatment drug Xeralto. 28 July 2016
Europe
The European Patent Office has announced several reforms to its patent opposition procedures. Stephanie Pilkington and Ling Zhuang of Potter Clarkson consider some of their implications for centralised patent revocation in Europe from a life sciences perspective. 28 July 2016
Big Pharma
GSK announced today that it will invest £275 million in expanding its UK manufacturing capabilities, despite Brexit. 27 July 2016
Americas
The US Court of Appeals for the Federal Circuit yesterday affirmed a district court’s order to deny arbitration in a patent infringement case between Illumina and Ariosa Diagnostics. 27 July 2016
Big Pharma
The Irish Pharmaceutical Healthcare Association has agreed a deal with the government that it says will reduce costs paid by the country’s Health Service Executive to facilitate access to new medicines. 26 July 2016